Article: Loratadine (Claritin) vs. desloratadine (Clarinex) formulary interchange.(Brief Article)

Article from:
Drug Utilization Review
Article date:
February 1, 2003
Author:
Copyright

Desloratadine (Clarinex), a major metabolite of loratadine (Claritin), is the newest medication indicated for the treatment of allergic rhinitis. It is often a misconception that new drugs are more beneficial than their predecessors. The information in the table on p. 6 has been provided in order to clarify the similarities between these two antihistamines.

The safety and efficacy of desloratadine is virtually identical to that of loratadine, the current formulary agent. Although ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Desloratadine: A once-daily nonsedating antihistamine for ...
Formulary;  May 1, 2001 ;     700+ words ...ABSTRACT Desloratadine is a new Hi-selective, nonse- dating oral ... One placebo-controlled trial has also shown desloratadine to significantly reduce symptoms of CIU flare. Desloratadine has an adverse effect profile comparable to ...

Article: Clinical Pharmacokinetics and Pharmacodynamics of ...
Clinical Pharmacokinetics;  April 1, 2008 ;     700+ words ... ... generation antihistamines - desloratadine, fexofenadine and levocetirizine ... inhibition has been reported with desloratadine, fexofenadine and levocetirizine, and the bioavailability of desloratadine is minimally affected by drugs ...

Article: Diphenhydramine more effective than desloratadine or ...
Clinical Advisor;  January 1, 2007 ;     700+ words ... ... DIPHENHYDRAMINE MORE EFFECTIVE THAN DESLORATADINE OR PLACEBO FOR SEASONAL ALLERGIC RHINITIS ... evidence Diphenhydramine (Benadryl) and desloratadine (Clarinex) were evaluated in a double ... diphenhydramine 50 mg three times daily, desloratadine 5 mg once daily, or placebo for one ...

Article: Examining the Tolerability of the Non-Sedating Antihistamine ...
Drug Safety;  February 1, 2009 ;     700+ words ...Abstract Background: Desloratadine is a non-sedating, long-acting ... Objective: To monitor the safety of desloratadine as prescribed in England, using ... general practitioners [GPs]) for desloratadine (March-May 2001); patient ...

Article: Desloratadine ameliorates QOL burden of CIU
Dermatology Times;  February 1, 2005 ;     700+ words ... ... selective H1-receptor antagonist desloratadine improves signs and symptoms of ... Canada to investigate the impact of desloratadine treatment in patients with CIU. Aerius is the tradename of desloratadine in Canada; it is marketed in the ...

Article: Europeans Enthusiastic About Desloratadine. (UNDER FDA ...
Skin & Allergy News;  November 1, 2001 ;     700+ words ...MUNICH -- Once-daily desloratadine is "an important therapeutic ... data or a specific indication. Desloratadine has been available in Germany ... antihistamines. In vitro studies suggest desloratadine's anti-inflammatory activity ...

Article: Desloratadine relieves seasonal allergic rhinitis, nasal ...
Immunotherapy Weekly;  January 22, 2003 ;     700+ words ... ... net) -- A recent study found desloratadine 5 mg safely and effectively relieves ... group, double-blind study of desloratadine 5 mg versus placebo." This was a safety and efficacy study of desloratadine 5 mg treatment in patients experiencing ...

Article: Sepracor Reports That Schering-Plough Submits U.S. Marketing ...
PR Newswire;  December 13, 2000 ;     700+ words ... ... formulations of its nonsedating antihistamine desloratadine. In December 1997, Schering-Plough ... to Sepracor's patents relating to desloratadine. The first NDA seeks clearance to market desloratadine syrup for the treatment of seasonal ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives